Küsimused

Hi I’m a journalist with Reuters in Shanghai, I write about health and pharma.

I’ve heard there may be some countries where there is no patent on semaglutide. Do you know if any companies in those countries are producing oral pill or injectible versions of semaglutide drugs (i.e. rybelsus generic/biosimilar) for consumers that are sold to people based in countries with patent protection (i.e. directly or via third-party distributors) like Estonia, and are there any examples you can share? Or how common such a phenomenon is, what countries are involved?

Appreciate your time,

-Andrew